Relationship between Duffy Genotype/Phenotype and Prevalence of Plasmodium vivax Infestation: A Systematic Review
Authors:
- Yelson Alejandro Picón-JaimesYelson Alejandro Picón-Jaimes
- Ivan David Lozada-MartinezILIvan David Lozada-Martinez
- Javier Esteban Orozco-ChinomeJOJavier Esteban Orozco-Chinome
- Jessica Molina-FrankyJMJessica Molina-Franky
- Domenica Acevedo-LopezDomenica Acevedo-Lopez
- Nicole Acevedo-LopezNANicole Acevedo-Lopez
- Maria Paz Bolaño-RomeroMBMaria Paz Bolaño-Romero
- Fabriccio Visconti-LopezFabriccio Visconti-Lopez
- D. Katterine Bonilla-AldanaDBD. Katterine Bonilla-Aldana
- Alfonso J. Rodriguez-MoralesAlfonso J. Rodriguez-Morales
Preprint
- 14 July 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The Duffy protein, a transmembrane molecule, functions as a receptor for various chemokines and facilitates attachment between the reticulocyte and the Plasmodium Duffy antigen-binding protein. Duffy expression correlates with the Duffy receptor gene for the chemokine, located on chromosome 1, and exhibits geographical variability worldwide. Traditionally, researchers have described the Duffy negative genotype as a protective factor against phenotypic malaria expression. However, recent studies suggest this microorganism's evolution potentially diminishes this protective effect. Nevertheless, there is currently insufficient global data to demonstrate this phenomenon. This study aimed to evaluate the relationship between the Duffy genotype/phenotype and the prevalence of Plasmodium vivax infection. The protocol for the systematic review was registered in PROSPERO as CRD42022353427 and involved reviewing published studies from 2012 to 2022. Medline, Web of Science, Scopus, and Scielo databases were consulted. Assessments of study quality were conducted using the STROBE and GRADE tools. A total of 34 studies were included, with Africa accounting for most recorded studies. The results varied significantly regarding the relationship between the Duffy genotype/phenotype and Plasmodium vivax invasion. Some studies predominantly featured the negative Duffy genotype yet reported no malaria cases. Other studies identified minor percentages of infections. Conversely, certain studies observed a higher prevalence (99%) of Duffy-negative individuals infected with Plasmodium vivax. In conclusion, no evidence of a gender-specific distribution of malaria between Duffy-negative men and women was found. However, evidence supports that the homozygous Duffy genotype positive for the A allele (FY*A/*A) is associated with a higher incidence of Plasmodium infection. Furthermore, the negative Duffy genotype does not confer protection against this disease.Keywords
All Related Versions
This publication has 51 references indexed in Scilit:
- Genotyping of ABO and Duffy blood groups among malaria patients in ThailandJournal of Parasitic Diseases, 2021
- Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cellsNature Microbiology, 2021
- The epidemiology of Plasmodium vivax among adults in the Democratic Republic of the CongoNature Communications, 2021
- Contrasting epidemiology and genetic variation of Plasmodium vivax infecting Duffy-negative individuals across AfricaInternational Journal of Infectious Diseases, 2021
- Estimated prevalence of the Duffy null phenotype Fy (a−b−) among black blood-donors in Southwestern ColombiaTransfusion and Apheresis Science, 2020
- Global prevalence of congenital malaria: A systematic review and meta-analysisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2020
- Amplification of Duffy binding protein-encoding gene allows Plasmodium vivax to evade host anti-DBP humoral immunityNature Communications, 2020
- Duffy antigen receptor for chemokines (DARC) and susceptibility to Plasmodium vivax malariaParasitology International, 2019
- Duffy blood group genotypes among malaria Plasmodium vivax patients of Baoulch population in southeastern IranAsian Pacific Journal of Tropical Medicine, 2014
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008